Search

Anti-TIGIT Antibodies Treat Cancers, Viral Infections

USPTO granted patent US12606619B2 to Huahui Health Ltd. on April 21, 2026. The patent covers human monoclonal antibodies targeting TIGIT (T-cell immunoreceptor with Ig and ITIM domains) and their use in treating immune-related diseases including cancers and viral infections. Inventors: Jianhua Sui, Fang Yang, Linlin Zhao, Zhizhong Wei. The application includes 21 claims.